Table 3 The rate and method of active participation of stakeholders in the development of health technology assessment reports
From: Impact assessment of Iran’s health technology assessment programme
Type of stakeholders | Are they stakeholders?a | Have they participated?b | At what level of participation?c | |||
|---|---|---|---|---|---|---|
Proposal preparation | Execution | Analysis | Conclusion | |||
Technology providers | 16 (80.0%) | 15 (80.0%) | 8 (53.3%) | 9 (60.0%) | 7 (46.7%) | 9 (60.0%) |
Companies importing or producing technology | 14 (70.0%) | 5 (35.7%) | 1 (20.0%) | 0 | 2 (40.0%) | 3 (60.0%) |
Policy-makers providing and allocating finances to technology | 16 (80.0%) | 11 (68.8%) | 4 (36.4%) | 5 (45.5%) | 1 (9.1%) | 7 (63.6%) |
Policy-makers regulating technology-related research and innovation needs | 13 (65.0%) | 3 (66.6%) | 2 (66.6%) | 0 | 0 | 1 (33.3%) |
Policy-makers regulating technology-related educational needs | 7 (35.0%) | 0 | 0 | 0 | 0 | 0 |
Public, patient associations, etc. | 11 (55.0%) | 0 | 0 | 0 | 0 | 0 |